With the rising global interest in medical weight loss treatments, two injectable medications have become household names: Wegovy and Mounjaro. Both are prescription drugs that help with significant and sustained weight reduction, but they work in slightly different ways. If you’re considering medical assistance for weight management, you’ve probably wondered – Wegovy or Mounjaro, which is better for weight loss?
This article explains how each medication works, their differences, and why one might be more suitable than the other. We also look at their approval status for use in Singapore, and what patients should know before starting treatment.
Consult A Doctor For Effective And Safe Weight Management
Contact UsBack To: Obesity In Singapore – The Big Story
Glossary Of Key Terms
- Agonist – A substance that activates a receptor in the body to produce a biological response.
- GLP-1 (Glucagon-Like Peptide-1) – A natural hormone that helps control appetite and blood sugar.
- GIP (Glucose-Dependent Insulinotropic Polypeptide) – A hormone that enhances the body’s insulin response.
- BMI (Body Mass Index) – A measure of body fat based on height and weight.
- Endocrinologist – A doctor who specialises in hormone-related disorders and metabolism.
What Is Wegovy?
Wegovy is the brand name for semaglutide, a medication originally developed to treat Type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which mimic a natural hormone in the body known as glucagon-like peptide-1 (GLP-1).
GLP-1 helps regulate blood sugar levels and slows down digestion, which helps you feel full for longer after eating. It also acts on the brain’s appetite centres to reduce hunger and food cravings.
When used at higher doses under medical supervision, Wegovy has been clinically proven to help individuals lose up to 15% of their body weight, making it one of the most effective non-surgical treatments for obesity available today.
What Is Mounjaro?
Mounjaro, whose active ingredient is tirzepatide, is a newer injectable medication that targets two hormones — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). Because it activates two different hormonal pathways, it is known as a dual agonist.
This dual action enhances both appetite control and insulin sensitivity, making it especially powerful for weight reduction. In clinical trials, Mounjaro users achieved average weight losses of 20% or more, surpassing the results typically seen with Wegovy.
Mounjaro was first approved for diabetes management and later for chronic weight management, showing exceptional results in patients who struggled to lose weight through diet and exercise alone.
Wegovy Or Mounjaro – Key Differences
While both medications aim to reduce body weight, their differences lie in how they act within the body and their overall effectiveness.
| Feature | Wegovy (Semaglutide) | Mounjaro (Tirzepatide) |
|---|---|---|
| Drug Class | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Mechanism | Mimics GLP-1 hormone to suppress appetite and slow digestion | Mimics both GLP-1 and GIP hormones for enhanced metabolic control |
| Average Weight Loss (Clinical Trials) | 15% of body weight | 20% or more of body weight |
| Administration | Once-weekly injection | Once-weekly injection |
| Approved For Weight Loss In Singapore | Yes (for adults meeting specific criteria) | Yes (for adults meeting specific criteria) |
| Common Side Effects | Nausea, constipation, mild stomach upset | Nausea, vomiting, fatigue, mild digestive issues |
While Mounjaro tends to show slightly higher weight loss results, some individuals respond better to Wegovy depending on their metabolism, health profile, and tolerance to side effects.
Why Are Wegovy And Mounjaro Approved In Singapore?
Both Wegovy and Mounjaro are approved in Singapore for weight management in adults who meet certain medical conditions, such as:
- Having a Body Mass Index (BMI) of ≥30 kg/m² (obese category), or
- A BMI of ≥27 kg/m² with at least one obesity-related condition such as high blood pressure, Type 2 diabetes, or high cholesterol.
These medications are available by prescription only, and patients must undergo evaluation by a registered doctor or endocrinologist before starting treatment. This ensures the drug is suitable for their medical profile and that side effects are properly managed.
Why You Might Prefer One Over The Other
1. Greater Weight Loss Potential
If you are seeking maximum fat reduction, Mounjaro may offer superior results based on current research. Its dual hormone mechanism provides a stronger metabolic response and improved control over appetite.
2. Better Tolerability For Some Users
While both can cause temporary nausea, some patients report that Wegovy is gentler on the digestive system, especially during the initial stages of treatment. Those who are more sensitive to gastrointestinal side effects may prefer Wegovy.
3. Underlying Health Conditions
Patients with Type 2 diabetes may benefit more from Mounjaro, as it improves both blood sugar and weight management simultaneously. For individuals without diabetes, Wegovy may be equally effective with potentially fewer blood sugar fluctuations.
4. Medical Availability And Cost
Availability and pricing may vary depending on your healthcare provider and insurance coverage. Wegovy has been available for longer, making it more widely prescribed, whereas Mounjaro is newer and may have more limited access depending on supply and demand.
5. Personal Response
Ultimately, every individual’s body reacts differently. An endocrinologist or qualified medical professional can evaluate your hormone levels, lifestyle, and medical history to determine which option is better suited for your weight management journey.
Our Preferred Doctors (Endocrinologist) For Weight Management Programmes
[SG] Featured Doctor- Dr Kevin Koo
Frequently Asked Questions (FAQs)
No. Both medications require a doctor’s prescription and medical supervision. They are approved for specific medical conditions and should only be used under the guidance of a licensed healthcare professional.
Clinical studies show that Mounjaro may produce faster and greater weight loss results compared to Wegovy, but this varies among individuals. Your doctor will help determine which medication best suits your health profile and goals.
When used under medical supervision, both medications have been shown to be safe for long-term use. Regular follow-ups with your doctor are essential to monitor progress, adjust dosage, and manage any side effects.
Not necessarily. Weight management should begin with a comprehensive assessment of your lifestyle, diet, physical activity, and hormonal health. Doctors often recommend trying evidence-based lifestyle changes first. Medications like Wegovy or Mounjaro are typically prescribed when other non-medical strategies have not produced sufficient results, or when medical conditions such as obesity or insulin resistance are present.
Seek Medical Guidance For Effective And Safe Weight Reduction
When it comes to Wegovy or Mounjaro, there is no one-size-fits-all answer. Both are powerful medical tools for effective weight management and have been approved in Singapore for patients who meet clinical requirements. The best choice depends on your body’s response, medical history, and preferences. Always consult a qualified doctor or endocrinologist before starting treatment to ensure safe and successful weight loss.
Contact UsBack To: Obesity In Singapore – The Big Story
All content on this site is informative only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment, and should never be relied upon for specific medical advice. If you are experiencing a medical emergency, call 995 immediately or go to the nearest Accident & Emergency department.
health365.sg is a member of Group 365Asia.